Semiquantitative immunohistochemical analysis for hypoxia in human tumors

International Journal of Radiation Oncology Biology Physics

Volumn 49, Issue 2, 2001, Pages 569-574

  Raleigh, James A ^a   Chou, Shu Chuan ^a   Bono, Erika L ^a   Thrall, Donald E ^b   Varia, Mahesh A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Immunohistochemical assay; Pimonidazole; Quantitation

Indexed keywords

HYPOXYPROBE-1; PIMONIDAZOLE; UNCLASSIFIED DRUG;

CLINICAL ARTICLE; CONFERENCE PAPER; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; HYPOXIA; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA;

CALIBRATION; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; NITROIMIDAZOLES; OBSERVER VARIATION; RADIATION-SENSITIZING AGENTS; UTERINE CERVICAL NEOPLASMS;

EID: 0035253549     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)01505-4     Document Type: Conference Paper

References (42)

1. Hypoxia-dependent reduction of 1-(2-nitro-1-imidazolyl)-3-methoxy-2-propanol by Chinese hamster ovary cells and KHT tumor cells in vitro and in vivo
2. Importance of thiols in the reductive binding of 2-nitroimidazoles to macromolecules
3. Regioselective formation of a misonidazole-glutathione conjugate as a function of pH during chemical reduction
4. Glutathione conjugates of misonidazole
5. Binding of misonidazole to hypoxic cells in monolayer and spheroid culture; evidence that a side-chain label is bound as efficiently as a ring label
6. Reductive metabolism of the hypoxia marker pimonidazole is regulated by oxygen tension independent of the pyridine nucleotide redox state
7. Evidence that hypoxia markers detect oxygen gradients in liver; pimonidazole and retrograde perfusion of rat liver
8. A marker for hypoxic cells in tumours with potential clinical applicability
9. 2 at the cellular level
10. Measuring tumor hypoxia
11. Covalent binding of a fluorinated 2-nitroimidazole to EMT-6 tumors in BALB/C mice; detection by F-19 nuclear magnetic resonance at 2.35T
12. Dynamic measurements of hexafluoromisonidazole (CCI-103F) retention in mouse tumours by 1H/19F magnetic resonance spectroscopy
13. 19F magnetic resonance method for measuring oxygen deficiency in tumors
14. Fluorescence immunohistochemical detection of hypoxic cells in spheroids and tumours
15. Immunohistochemical detection of a hypoxia marker in spontaneous canine tumours
16. Distribution of the hypoxia marker CCI-103F in canine tumors
17. ELISA quantification of CCI-103F binding in canine tumors prior to and during irradiation
18. Hypoxia marker labeling in tumor biopsies; quantification of labeling variation and criteria for biopsy sectioning
19. Quantification of CCI-103F labeling heterogeneity in canine solid tumors
20. Longevity of pimonidazole adducts in spontaneous canine tumors as an estimate of hypoxic cell lifetime
21. A clinical study of hypoxia and metallothionein protein expression in squamous cell carcinomas
22. Detection of hypoxia in human squamous cell carcinoma by EF5 binding
23. Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker
24. Pimonidazole; a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma
25. Proliferation and hypoxia in human squamous cell carcinoma of the cervix; first report of combined immunohistochemical assays
26. Relationship of hypoxia to metallothionein expression in murine tumors
27. Use of 2-nitroimidazoles as bioreductive markers for tumour hypoxia
28. Co-localization of hypoxia and apoptosis in irradiated and untreated HCT116 human colon carcinoma xenografts
29. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
30. Mapping of the vascular endothelial growth factor-producing hypoxic cells in multicellular tumor spheroids using a hypoxia-specific marker
31. Distribution of hypoxia and proliferation associated markers in spontaneous canine tumors
32. Secretion rates and levels of vascular endothelial growth factor in clone A or HCT-8 human colon tumour cells as a function of oxygen concentration
33. Activation of metallothionein gene expression by hypoxia involves metal response elements and MTF-1
34. Identification of nonproliferating but viable hypoxic cells in vivo
35. Simultaneous triple staining for hypoxia, proliferation, and DNA content in murine tumours
36. Vascular architecture and hypoxic profiles in human head and neck squamous cell carcinomas
37. Novel (nitro-1-imidazoyl)-alkanolamines as potential radiosensitizers with improved therapeutic properties
38. The clinical testing of Ro 03-8799-pharmacokinetics, toxicology, tissue and tumor concentrations
39. Comparisons among pimonidazole binding, oxygen electrode measurements and radiation response in C3H mouse tumors
40. Chronic enteral ethanol treatment causes hypoxia in rat liver tissue in vivo
41. Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography